Unknown

Dataset Information

0

Representation of CYP3A4, CYP3A5 and UGT1A4 Polymorphisms within Croatian Breast Cancer Patients' Population.


ABSTRACT: Single nucleotide polymorphism (SNP) in genes encoding drug-metabolizing enzymes (DME) could have a critical role in individual responses to anastrozole. Frequency of CYP3A4*1B, CYP3A5*3 and UGT1A4*2 SNPs in 126 Croatian breast cancer (BC) patients and possible association with anastrozole-induced undesirable side effects were analyzed. Eighty-two postmenopausal patients with estrogen receptor (ER)-positive BC treated with anastrozole and 44 postmenopausal ER-positive BC patients before hormonal adjuvant therapy were included in the study. Genomic DNA was genotyped by TaqMan Real-Time PCR. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry. The homozygotes for the variant G allele of CYP3A5*3 were predominant (88%), and the homozygotes for the reference A allele were not detected. While homozygotes for the variant G allele of CYP3A4*1B were not detected, predominantly wild type homozygotes for A allele (94%) were present. CYP3A4*1B and CYP3A5*3 SNPs were in 84.3% linkage disequilibrium (D' = 0.843) and 95.1% (D' = 0.951) in group treated with anastrozole and w/o treatment, respectively. Homozygotes for the A allele of UGT1A4*2 were not detected in our study groups. Although the variant CYP3A5*3 allele, which might result in poor metabolizer phenotype and more pronounced side effects, was predominant, significant association with BMD changes induced by anastrozole were not confirmed.

SUBMITTER: Bojanic K 

PROVIDER: S-EPMC7277422 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Representation of CYP3A4, CYP3A5 and UGT1A4 Polymorphisms within Croatian Breast Cancer Patients' Population.

Bojanic Kristina K   Kuna Lucija L   Bilic Curcic Ines I   Wagner Jasenka J   Smolic Robert R   Kralik Kristina K   Kizivat Tomislav T   Ivanac Gordana G   Vcev Aleksandar A   Wu George Y GY   Smolic Martina M  

International journal of environmental research and public health 20200523 10


Single nucleotide polymorphism (SNP) in genes encoding drug-metabolizing enzymes (DME) could have a critical role in individual responses to anastrozole. Frequency of CYP3A4*1B, CYP3A5*3 and UGT1A4*2 SNPs in 126 Croatian breast cancer (BC) patients and possible association with anastrozole-induced undesirable side effects were analyzed. Eighty-two postmenopausal patients with estrogen receptor (ER)-positive BC treated with anastrozole and 44 postmenopausal ER-positive BC patients before hormonal  ...[more]

Similar Datasets

| S-EPMC3874433 | biostudies-literature
| S-EPMC10523700 | biostudies-literature
| S-EPMC7235792 | biostudies-literature
| S-EPMC1925111 | biostudies-literature
| S-EPMC6925622 | biostudies-literature
| S-EPMC5315081 | biostudies-literature
| S-EPMC3850616 | biostudies-other
| S-EPMC6265082 | biostudies-literature
| S-EPMC3093079 | biostudies-literature
| S-EPMC8685429 | biostudies-literature